Live from the NIH registry
Studies recruiting near Atlanta right now
Top 25 of 1,711 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
Emory University and Children's Healthcare of Atlanta — Atlanta, Georgia (2.2 mi)
· Sponsor: University of Michigan
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Lymphoma, Non-Hodgkin, Multiple Myeloma
Phase 2
Interventional 4,200 participants sought
Cancer Treatment Centers of America - Atlanta — Atlanta, Georgia (2.2 mi)
· Sponsor: American Society of Clinical Oncology
A Phase 3 Study of Tabelecleucel for Participants With Epstein-Barr Virus-Associated Post-Transplant Lymphoproliferative Disease After Failure With Rituximab or Rituximab and Chemotherapy
Epstein-Barr Virus+ Associated Post-transplant Lymphoproliferative Disease (EBV+ PTLD), Solid Organ Transplant Complications
Phase 3
Interventional 115 participants sought
Winship Cancer Institute (Adults only) — Atlanta, Georgia (2.2 mi)
· Sponsor: Pierre Fabre Medicament
A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
Chronic Graft-versus-host-disease
Phase 2
Interventional 296 participants sought
Emory University — Atlanta, Georgia (2.2 mi)
· Sponsor: Syndax Pharmaceuticals
Extracorporeal Photopheresis in Sezary Syndrome
Sezary Syndrome
N/A
Observational 20 participants sought
Emory University School of Medicine — Atlanta, Georgia (2.2 mi)
· Sponsor: Oleg E. Akilov, MD, PhD
Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
Endometrial Cancer
Phase 2, Phase 3
Interventional 268 participants sought
Northside Hospital — Atlanta, Georgia (2.2 mi)
· Sponsor: Kartos Therapeutics, Inc.
Inflammation and Depression in People With HIV
HIV, Depression
Phase 2
Interventional 60 participants sought
Grady Memorial Hospital — Atlanta, Georgia (2.2 mi)
· Sponsor: Emory University
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
Multiple Myeloma
Phase 1, Phase 2
Interventional 226 participants sought
Research Site — Atlanta, Georgia (2.2 mi)
· Sponsor: AstraZeneca
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Children's Healthcare of Atlanta - Arthur M Blank Hospital — Atlanta, Georgia (2.2 mi)
· Sponsor: National Cancer Institute (NCI)
Isunakinra Alone and in Combination With Pembrolizumab in Patients With Colorectal Cancer (MSS)
Colorectal Cancer Metastatic
Phase 2
Interventional 20 participants sought
Emory University — Atlanta, Georgia (2.2 mi)
· Sponsor: Buzzard Pharmaceuticals
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Ponce de Leon — Atlanta, Georgia (2.2 mi)
· Sponsor: Westat
Off-Label Medications for Alcohol Use Disorder Among Patients With HIV: Pilot Study 3 Semaglutide
Alcohol Use Disorder (AUD), HIV
Phase 2
Interventional 30 participants sought
Atlanta VA Medical Center — Decatur, Georgia (7.3 mi)
· Sponsor: Yale University
A Protocol of Icotrokinra Therapy in Adult and Adolescent Participants With Moderately to Severely Active Ulcerative Colitis
Colitis, Ulcerative
Phase 3
Interventional 882 participants sought
Atlanta Gastroenterology Associates — Atlanta, Georgia (2.2 mi)
· Sponsor: Janssen Research & Development, LLC
A Study to Determine the Effects of ENDS Flavor Availability on Abstinence Within Smokers
Smoking, Tobacco
N/A
Interventional 1,280 participants sought
Sago Atlanta — Atlanta, Georgia (2.2 mi)
· Sponsor: RAI Services Company
Targeted Therapy to Increase RAI Uptake in Metastatic DTC
Papillary Thyroid Cancer, Pediatric Cancer
N/A
Observational 32 participants sought
Emory University School of Medicine — Atlanta, Georgia (2.2 mi)
· Sponsor: Children's Hospital of Philadelphia
A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
FSGS
Phase 3
Interventional 286 participants sought
Emory University School of Medicine — Atlanta, Georgia (2.2 mi)
· Sponsor: Dimerix Bioscience Pty Ltd
Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Multiple conditions
Phase 2
Interventional 28 participants sought
Emory University Hospital Midtown — Atlanta, Georgia (2.2 mi)
· Sponsor: Emory University
A Study Evaluating the Efficacy and Safety of Inavolisib Plus CDK4/6 Inhibitor and Letrozole vs Placebo + CDK4/6i and Letrozole in Participants With Endocrine-Sensitive PIK3CA-Mutated, Hormone Receptor-Positive, HER2-Negative Advanced Breast Cancer
Breast Cancer
Phase 3
Interventional 450 participants sought
Northwest Georgia Oncology Centers PC - Marietta — Marietta, Georgia (15.0 mi)
· Sponsor: Hoffmann-La Roche
Early Use of Tacrolimus in HLA-Mismatched Haploidentical Allogeneic Hematopoietic Transplantation With Post-Transplant Cyclophosphamide
Hematologic Disease and Disorders, Hematopoietic Cell Transplant
Phase 2
Interventional 20 participants sought
Northside Hospital — Atlanta, Georgia (2.2 mi)
· Sponsor: Northside Hospital, Inc.
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Emory University School of Medicine — Atlanta, Georgia (2.2 mi)
· Sponsor: Jaeb Center for Health Research
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer
Phase 3
Interventional 590 participants sought
Piedmont Healthcare, Inc — Atlanta, Georgia (2.2 mi)
· Sponsor: Revolution Medicines, Inc.
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Atlanta, GA — Atlanta, Georgia (2.2 mi)
· Sponsor: Mediar Therapeutics
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
Solid Tumor, Non-Small-Cell Lung Cancer
Phase 1
Interventional 404 participants sought
Winship Cancer Institute at Emory University — Atlanta, Georgia (2.2 mi)
· Sponsor: Astellas Pharma Inc
Compassionate Use Study of Epi-ON Corneal Collagen Crosslinking Performed Using UVA Exposure on Eyes With Ectatic Corneal Diseases for Subjects With Down Syndrome
Down Syndrome (DS), Keratoconus
Phase 3
Interventional 225 participants sought
Woolfson Eye Institute — Atlanta, Georgia (2.2 mi)
· Sponsor: Woolfson Eye Institute
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Emory University School of Medicine — Atlanta, Georgia (2.2 mi)
· Sponsor: Medtronic MiniMed, Inc.